AI-168 (Accuthera)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameAI-168 (Accuthera)
Drug Alias NameAI-168 (Accuthera)AI-168
ClassificationSmall molecules > Peptidomimetic
Mechanisms of ActionLeukocyte elastase inhibitorsLeukocyte proteinase 3 inhibitors
TargetsLeukocyte elastaseLeukocyte proteinase 3
Therapy Area/IndicationsInflammationRespiratory Tract Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAccuthera LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAccuthera LLC
Active IndicationsN/A
Inactive IndicationsInflammationRespiratory Tract Diseases

Other Information

ATC CodeN/A
Related LinksN/A